This medication is accessible only beneath a Distinctive limited distribution application termed Qsymia® REMS program.Qsymia has a combination of phentermine HCl and topiramate extended-release. It's now available in 4 distinctive doses.Heart valve problems: Extended use (above three months) might cause heart valve defects like leaky mitral and ao